$2.01B in Funding Deals and 71 Companies Added

CipherBio Weekly Digest: Week of Feb 17 – Feb 23, 2022

Top 5 Deals This Week

Minded, New York-based digital health/AI company, raises $25M in Seed round from various investors. Plexium raises $102M in Series A led by BVF Partners, L.P. and TCG X. Equip Health raises $58M in Series B led by The Chernin Group. In Series E  Somatus raises $325M led by Wellington Management. Sirona Medical acquires Nines for an undisclosed amount.

Company	Round	Amount
Minded	Seed	$25M
Plexium	Series A	$102M
Equip Health	Series B	$58M
Somatus	Series E	$325M
Nines	Acquisition	Undisclosed

Top Deals by Product and Clinical Phases

NovelMed announces phase 1 clinical trial of NM8074. In phase 2 Evelo Biosciences announces trial of EDP1815 in Atopic Dermatitis. Belgium-based Pharmazz announces phase 3 clinical trial of Sovateltide for ischemic stroke. Senseonics announces FDA approval of Eversense E3 CGM System.

Company	Product and Clinical Phase	Indications
NovelMed	NM8074,  Phase 1	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Evelo Biosciences	EDP1815, Phase 2	Atopic Dermatitis, Allergic Diseases
Pharmazz	Sovateltide, Phase 3	Ischemic Stroke
Senseonics	Pure-Vu® EVS System, FDA Cleared	Diabetes

71 Life Science Companies Added

This week we added 71 life science companies to our platform.

Hyphen	Semaai	NovelMed
Ageless Biotech	TargED Biopharmaceuticals	High Tide Therapeutics
MediBuddy	Heyy	ProJenX

To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.